scispace - formally typeset
D

Derek R. Robinson

Researcher at University of Sussex

Publications -  59
Citations -  2350

Derek R. Robinson is an academic researcher from University of Sussex. The author has contributed to research in topics: Myocardial infarction & Heart transplantation. The author has an hindex of 22, co-authored 59 publications receiving 1999 citations.

Papers
More filters
Journal ArticleDOI

Antivimentin antibodies are an independent predictor of transplant-associated coronary artery disease after cardiac transplantation.

TL;DR: Antivimentin antibodies are an independent predictor of TxCAD and can be used to identify some of the patients who are at high risk of developing this complication.
Journal ArticleDOI

De novo donor HLA-specific antibodies after heart transplantation are an independent predictor of poor patient survival.

TL;DR: Patients who are transplanted in the absence of pre‐existing DSA make de novo DSA after transplantation which are associated with poor survival, and early and regular monitoring of post‐transplant DSA is required to identify patients at risk of allograft failure.
Journal ArticleDOI

A Comprehensive Evaluation of Rhythm Monitoring Strategies for the Detection of Atrial Fibrillation Recurrence: Insights from 647 Continuously Monitored Patients and Implications for Monitoring After Therapeutic Interventions

TL;DR: Investigation of the sensitivity of various frequencies and durations of IRM strategies on the detection of atrial fibrillation recurrence found that IRM follow-up is significantly inferior to CM, and patients with high-density, low-burden AF benefit the most from CM for detection of AF recurrence.
Journal ArticleDOI

High-Speed Rotational Atherectomy Versus Modified Balloons Prior to Drug-Eluting Stent Implantation in Severely Calcified Coronary Lesions

TL;DR: Lesion preparation with upfront RA before drug-eluting stent implantation is feasible in nearly all patients with severely calcified coronary lesions, is more commonly successful as a primary strategy compared with MB, and is not associated with excessive late lumen loss.
Journal ArticleDOI

1-Year Outcomes After Transcatheter Aortic Valve Replacement With Balloon-Expandable Versus Self-Expandable Valves: Results From the CHOICE Randomized Clinical Trial.

TL;DR: Despite the higher device success rate with the balloon-expandable valve, 1-year follow-up of patients in CHOICE revealed clinical outcomes after transfemoral transcatheter aortic valve replacement with both balloon- and self-Expandable prostheses that were not statistically significantly different.